“…Survival Laminin-α2 on axons Increased survival (Colognato et al, 2002) Laminin-α2 knockout Fewer OPCs and increased cell death (Relucio et al, 2012) Laminin-411 and À 511 Increased survival (Suzuki et al, 2019) Laminin-211 with PDGF Increased survival (Colognato et al, 2004;Decker, 2004;Frost et al, 1999) Laminin substrate Decreased OPC death (Hu et al, 2009) Integrin-α6β1 blockage Reduced survival (Corley et al, 2001;Frost et al, 1999) Lipid raft depletion Increased apoptosis (Decker, 2004) Integrin-α6 knockout Increased cell death (Colognato et al, 2002) Integrin-αv/α6 chimera Increased survival (Colognato et al, 2002) Integrin-β1 CKO a (CNP-Cre) Increased cell death (Benninger et al, 2006) Laminin with dystroglycan blockage No significant change (Colognato et al, 2007) Migration Laminin substrate Increased migration (Milner et al, 1996;Schmidt et al, 1997) Laminin-211 Increased migration (Frost et al, 1996) Laminin-211, À411 and À 511 Increased migration (Suzuki et al, 2019) Laminin Increased migration (Fok-Seang et al, 1995) Integrin-β1 blockage Reduced migration (Milner et al, 1996) Integrin-α6 blockage No significant change (Milner et al, 1996) Integrin…”